CLINICAL_TRIALS
trial_result
· 2025-02-10
Clinical Trial Update: A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Olpasiran in Chinese Participants With Elevated Serum Lipoprotein(a) [Phase 1]
Summary
Phase 1 trial evaluating pharmacokinetics, pharmacodynamics, safety and tolerability of Olpasiran in Chinese participants with elevated serum lipoprotein(a); re…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Elevated Serum Lipoprotein(a) | Phase 1 | Status: COMPLETED | Results posted: 2025-02-10